Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
On 25 September 2025, the EPO’s Enlarged Board of Appeal (‘EBoA’) issued its decision in case G 2/24, the third…
Read More
For many SMEs, intellectual property (IP) is treated as a defensive measure – something to protect against theft or infringement….
Read More
In the context of intellectual property (IP), a hidden and potentially costly issue with using AI tools is confidentiality. This…
Read More
According to a recent exchange between Barker Brettell and The European Patent Office (EPO), it is about to modernise its…
Read More
Over the past few years, the issue of whether the description of a European patent or application should be amended…
Read More
A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read More
The EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
Read More
The Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
Read More
Following the SkyKick v. Sky decision – which we covered in an earlier article – the key takeaway was that…
Read More
This article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
Read More
According to a recent BBC article, US festival brand Coachella has forced Steps star Ian “H” Watkins to change the…
Read More